{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:29:42Z","timestamp":1761514182453},"reference-count":9,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jid.2018.03.1519","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T08:27:13Z","timestamp":1522398433000},"page":"2286-2288","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum Soluble CD48 Levels as a\u00a0Prognostic\u00a0Marker in\u00a0Mycosis Fungoides and\u00a0S\u00e9zary Syndrome"],"prefix":"10.1016","volume":"138","author":[{"given":"Tomonori","family":"Oka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomitsu","family":"Miyagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kamijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiraku","family":"Suga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.03.1519_bib1","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1084\/jem.188.11.2083","article-title":"2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48","volume":"188","author":"Brown","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2018.03.1519_bib2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/all.13082","article-title":"CD48 on blood leukocytes and in serum of asthma patients varies with severity","volume":"72","author":"Gangwar","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jid.2018.03.1519_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.jid.2018.03.1519_bib4","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.4049\/jimmunol.161.11.5809","article-title":"Identification of the 2B4 molecule as a counter-receptor for CD48","volume":"161","author":"Latchman","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2018.03.1519_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2016.01.008","article-title":"Roles of CD48 in regulating immunity and tolerance","volume":"164","author":"McArdel","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2018.03.1519_bib6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and S\u00e9zary syndrome: a proposal of the International Society for Cutaneous Lymphomas and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.03.1519_bib7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1023\/A:1027327912204","article-title":"Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis","volume":"17","author":"Smith","year":"1997","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jid.2018.03.1519_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archderm.1996.03890250052009","article-title":"Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications","volume":"132","author":"Wasik","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2018.03.1519_bib9","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18318554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18318554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T21:13:39Z","timestamp":1693602819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X18318554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0022202X18318554"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.03.1519","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Soluble CD48 Levels as a\u00a0Prognostic\u00a0Marker in\u00a0Mycosis Fungoides and\u00a0S\u00e9zary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.03.1519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}